• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY Back to Search Results
Model Number ANTI-TSHR
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/08/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi): (b)(4).The investigation is ongoing.
 
Event Description
The initial reporter had switched from version one (1) to version two (2) of the elecsys anti-tshr (anti-tshr) assay on a cobas e801 module and noted that the number of samples with results of <0.8 iu/l had decreased.The initial results from version two (2) of the assay were reported outside of the laboratory where the physician requested additional testing.The customer performed a comparison between the different versions for 23 patient samples.Of this data, the results for one (1) patient sample were discrepant.The customer is not sure which results are correct.The 23 patient samples were submitted for investigation where the results for one (1) additional patient sample were discrepant.This medwatch will cover the anti-tshr version one (1).Refer to medwatch with a1 patient identifier (b)(6) for information on the anti-tshr version two (2) results.Refer to attached data for the results.The e801 module serial number at the customer site was (b)(4).The e801 module used at the investigation site was (b)(4).The reagent lots used were: anti-tshr v1 lot 485820 with an expiration date of nov-2021.Anti-tshr v2 lot 473426 with an expiration date of aug-2021 and, anti-tshr v2 lot 505102 with an expiration date of jan-2022.
 
Manufacturer Narrative
The initial report stated: "the e801 module serial number at the customer site was (b)(6)." the cobas 8000 core unit serial number was (b)(6).The serial number for the e801 module used at the customer site was not provided.Calibration and qc were acceptable.Only the initial run at the customer site were slightly elevated; all the following repeat results were comparable.The cutoff used in japan is 2.0 iu/l, therefore, all results were below the cutoff leading to the same clinical interpretation of 'negative.' most of the results were between <0.8 iu/l and 1.1 iu/l, however, some single results were slightly higher.All samples were below or near the limit of quantification (loq) which explains the deviations.Based on the data provided, the investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR
Type of Device
ANTI-TSHR IMMUNOASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11586264
MDR Text Key245549752
Report Number1823260-2021-00953
Device Sequence Number1
Product Code JZO
Combination Product (y/n)N
PMA/PMN Number
K080092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Model NumberANTI-TSHR
Device Catalogue Number07026951190
Device Lot Number485820
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/08/2021
Initial Date FDA Received03/29/2021
Supplement Dates Manufacturer Received03/08/2021
Supplement Dates FDA Received04/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-